EUVIMEDEUVIMED entdecken
Crossref

Exploring anti-lipid droplet accumulation components from Anredera cordifolia using bioactivity-coupled MS/MS molecular networking

J-H Cheng, H-C Wu, C-H Yen, A Gu, H-S Chang

Planta Medica · 01.03.2026 · 92 (03) · 300

DOI: 10.1055/s-0045-1815135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.03.2026. Verfasst von J-H Cheng und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The integration of tandem mass spectrometry (MS/MS)-based molecular networking (MN) with bioactivity-guided screening offers an efficient approach for isolating active compounds, substantially streamlining the purification process. Using a high-throughput screening platform, we evaluated the Taiwan edible plant for food extracts bank for anti-lipid droplet (LD) accumulation activity. The ethanolic extract of Anredera cordifolia (Ten.) Steenis leaves demonstrated remarkable inhibitory effects, suggesting its considerable potential as a reservoir of therapeutic compounds. We implemented a bioactivity-coupled MS/MS molecular networking strategy to identify potential anti-LD accumulation agents from this edible plant. This approach yielded one new compound ( AC-3 ) and 26 known compounds spanning diverse chemical classes: one aliphatic ( AC-4 ), one alkaloid ( AC-5 ), four apocarotenoids ( AC-69 ), 11 benzenoids ( AC-1021 ), three chlorophylls ( AC-1 , 2 , and 22 ), one coumarin ( AC-23 ), one diterpenoid ( AC-24 ), and three steroids ( AC-2527 ). Notably, our bioactivity assessment revealed that two chlorophyll compounds ( AC-1 and 2 ) exhibited pronounced inhibition of LD accumulation. These findings complement our earlier research, wherein methyl pheophorbide a — a chlorophyll derivative isolated from Elaeagnus glabra Thunb.—demonstrated significant anti-LD activity, further validating the therapeutic potential of chlorophyll-derived compounds. Collectively, our findings highlight the rich phytochemical diversity and biological significance of A. cordifolia , establishing a robust foundation for its development as a natural therapeutic intervention for metabolic-associated fatty liver disease [ 1 ]. Publication History Article published online: 05 March 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Zitieren

APA

Cheng, J., Wu, H., Yen, C., Gu, A., & Chang, H. (2026). Exploring anti-lipid droplet accumulation components from Anredera cordifolia using bioactivity-coupled MS/MS molecular networking. Planta Medica, 92(03), 300. https://doi.org/10.1055/s-0045-1815135

Vancouver

Cheng J, Wu H, Yen C, Gu A, Chang H. Exploring anti-lipid droplet accumulation components from Anredera cordifolia using bioactivity-coupled MS/MS molecular networking. Planta Medica. 2026;92(03):300. doi:10.1055/s-0045-1815135

BibTeX
@article{Cheng2026,
  author = {Cheng, J-H and Wu, H-C and Yen, C-H and Gu, A and Chang, H-S},
  title = {Exploring anti-lipid droplet accumulation components from Anredera cordifolia using bioactivity-coupled MS/MS molecular networking},
  journal = {Planta Medica},
  year = {2026},
  volume = {92},
  number = {03},
  pages = {300},
  doi = {10.1055/s-0045-1815135}
}
Kostenlos starten →